During the past decade, Ospedale Civile Ramazzini conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 5 clinical trials were completed, i.e. on average, 45.5% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale Civile Ramazzini" #1 sponsor was "ETOP IBCSG Partners Foundation" with 3 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 3 trials sponsored, "National Cancer Institute, Naples" with 3 trials sponsored, "Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo" with 1 trials sponsored and "Azienda Ospedaliero-Universitaria di Parma" with 1 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Civile Ramazzini" #1 collaborator was "Breast International Group" with 3 trials as a collaborator, "ETOP IBCSG Partners Foundation" with 3 trials as a collaborator, "Gruppo Oncologico Italiano di Ricerca Clinica" with 2 trials as a collaborator, "National Cancer Institute (NCI)" with 2 trials as a collaborator and "UNICANCER" with 2 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Civile Ramazzini" are "Breast Cancer" (6 trials), "Non-small Cell Lung Cancer Metastatic" (2 trials), "Non-small Cell Lung Cancer Stage IIIB" (2 trials), "Prostate Cancer" (2 trials) and "Acute Coronary Syndromes" (1 trials). Many other conditions were trialed in "Ospedale Civile Ramazzini" in a lesser frequency.

Most popular intervention types in "Ospedale Civile Ramazzini" are "Drug" (19 trials), "Other" (4 trials), "Device" (3 trials), "Procedure" (3 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Cisplatin" (2 trials), "Gemcitabine" (2 trials), "Palbociclib" (2 trials), "cyclophosphamide" (2 trials) and "Alectinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Civile Ramazzini" are 18 trials for "All" genders, 6 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Ospedale Civile Ramazzini". undefined are not yet recruiting, 4 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Ospedale Civile Ramazzini, 1 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Civile Ramazzini, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".